Measles and mumps combined vaccine, live attenuated (Chengdu Institute of Biological Products)

麻疹-腮腺炎二联活疫苗（成都生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles and mumps combined vaccine, live attenuated (Chengdu Institute of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParotitisMeasles

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (NDA/BLA)

Highest Status in ChinaPending

Originator CompaniesChengdu Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai Institute of Biological Products Co Ltd

Active IndicationsN/A

Inactive IndicationsParotitisMeasles

Other Information

ATC CodeN/A